Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$5.72
+0.5%
C$5.50
C$4.35
C$5.95
C$578.69M0.4972,630 shs2,811 shs
Hollysys Automation Technologies Ltd. stock logo
HOLI
Hollysys Automation Technologies
$24.52
+0.4%
$25.44
$15.13
$27.25
$1.52B0.53668,699 shs6,408 shs
Kadant Inc. stock logo
KAI
Kadant
$281.31
+0.6%
$313.98
$183.49
$354.02
$3.30B1.2790,813 shs3,464 shs
Enpro Inc. stock logo
NPO
Enpro
$151.45
+1.4%
$158.39
$92.88
$170.63
$3.17B1.5595,951 shs5,419 shs
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
-0.52%-1.73%+4.79%+1.61%+18.54%
Hollysys Automation Technologies Ltd. stock logo
HOLI
Hollysys Automation Technologies
-0.37%+0.49%-4.68%-3.78%+54.72%
Kadant Inc. stock logo
KAI
Kadant
-2.21%-1.38%-13.23%+2.00%+51.93%
Enpro Inc. stock logo
NPO
Enpro
-0.83%+0.42%-6.66%-5.20%+62.28%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
0.7716 of 5 stars
2.50.00.00.00.03.30.6
Hollysys Automation Technologies Ltd. stock logo
HOLI
Hollysys Automation Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Kadant Inc. stock logo
KAI
Kadant
1.5311 of 5 stars
1.30.03.30.02.82.51.9
Enpro Inc. stock logo
NPO
Enpro
1.4584 of 5 stars
0.02.01.71.42.62.51.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
3.00
BuyC$6.5815.09% Upside
Hollysys Automation Technologies Ltd. stock logo
HOLI
Hollysys Automation Technologies
N/AN/AN/AN/A
Kadant Inc. stock logo
KAI
Kadant
2.67
Moderate Buy$300.006.64% Upside
Enpro Inc. stock logo
NPO
Enpro
N/AN/A$158.004.32% Upside

Current Analyst Ratings

Latest NPO, KAI, GUD, HOLI, and AVON Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/22/2024
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperformC$6.50 ➝ C$7.00
3/6/2024
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperformC$7.00 ➝ C$7.50
2/28/2024
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOutperformC$7.00
2/14/2024
Kadant Inc. stock logo
KAI
Kadant
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$300.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$328.20M1.76C$1.49 per share3.85C$7.38 per share0.78
Hollysys Automation Technologies Ltd. stock logo
HOLI
Hollysys Automation Technologies
$777.37M1.95$1.96 per share12.48$18.97 per share1.29
Kadant Inc. stock logo
KAI
Kadant
$957.67M3.45$12.70 per share22.15$66.31 per share4.24
Enpro Inc. stock logo
NPO
Enpro
$1.06B2.99$14.02 per share10.80$67.43 per share2.25

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
-C$16.84M-C$0.16N/AN/A-5.13%-2.14%0.40%5/9/2024 (Estimated)
Hollysys Automation Technologies Ltd. stock logo
HOLI
Hollysys Automation Technologies
$106.93M$1.3418.30N/A10.56%7.09%4.89%5/21/2024 (Estimated)
Kadant Inc. stock logo
KAI
Kadant
$116.07M$9.9028.4225.90N/A12.12%16.20%10.11%5/7/2024 (Estimated)
Enpro Inc. stock logo
NPO
Enpro
$22.20M$1.06142.8818.86N/A2.10%9.67%5.32%5/7/2024 (Confirmed)

Latest NPO, KAI, GUD, HOLI, and AVON Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Enpro Inc. stock logo
NPO
Enpro
$1.54N/A-$1.54N/AN/AN/A  
3/21/2024Q4 2023
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$0.02-C$0.03-C$0.05C$0.17C$78.37 millionC$74.20 million
3/7/2024Q2 2024
Hollysys Automation Technologies Ltd. stock logo
HOLI
Hollysys Automation Technologies
N/A$0.23+$0.23$0.23N/A$223.72 million
2/20/202412/31/2023
Enpro Inc. stock logo
NPO
Enpro
$1.47$1.19-$0.28$2.61$264.10 million$241.90 million      
2/14/2024Q4 2023
Kadant Inc. stock logo
KAI
Kadant
$2.10$2.41+$0.31$2.49$227.54 million$238.68 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
N/AN/AN/AN/AN/A
Hollysys Automation Technologies Ltd. stock logo
HOLI
Hollysys Automation Technologies
N/AN/AN/AN/AN/A
Kadant Inc. stock logo
KAI
Kadant
$1.280.46%+5.95%12.93%11 Years
Enpro Inc. stock logo
NPO
Enpro
$1.200.79%+3.71%113.21%9 Years

Latest NPO, KAI, GUD, HOLI, and AVON Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/6/2024
Kadant Inc. stock logo
KAI
Kadant
quarterly$0.320.4%4/9/20244/10/20245/8/2024
2/15/2024
Enpro Inc. stock logo
NPO
Enpro
quarterly$0.300.7%3/5/20243/6/20243/20/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
9.25
3.20
1.79
Hollysys Automation Technologies Ltd. stock logo
HOLI
Hollysys Automation Technologies
0.04
2.90
2.70
Kadant Inc. stock logo
KAI
Kadant
0.14
2.05
1.34
Enpro Inc. stock logo
NPO
Enpro
0.45
3.31
2.59

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
13.67%
Hollysys Automation Technologies Ltd. stock logo
HOLI
Hollysys Automation Technologies
78.67%
Kadant Inc. stock logo
KAI
Kadant
96.13%
Enpro Inc. stock logo
NPO
Enpro
98.31%

Insider Ownership

CompanyInsider Ownership
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
46.45%
Hollysys Automation Technologies Ltd. stock logo
HOLI
Hollysys Automation Technologies
5.71%
Kadant Inc. stock logo
KAI
Kadant
1.40%
Enpro Inc. stock logo
NPO
Enpro
1.60%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
725101.17 millionN/ANot Optionable
Hollysys Automation Technologies Ltd. stock logo
HOLI
Hollysys Automation Technologies
5,04261.85 million58.32 millionOptionable
Kadant Inc. stock logo
KAI
Kadant
3,10011.74 million11.58 millionOptionable
Enpro Inc. stock logo
NPO
Enpro
3,50020.94 million20.61 millionOptionable

NPO, KAI, GUD, HOLI, and AVON Headlines

SourceHeadline
Enpro Announces Date for First Quarter 2024 Earnings Release and Conference CallEnpro Announces Date for First Quarter 2024 Earnings Release and Conference Call
finance.yahoo.com - April 23 at 5:05 PM
Jennison Associates LLC Increases Position in Enpro Inc. (NYSE:NPO)Jennison Associates LLC Increases Position in Enpro Inc. (NYSE:NPO)
marketbeat.com - April 23 at 8:37 AM
Louisiana State Employees Retirement System Acquires Shares of 10,500 Enpro Inc. (NYSE:NPO)Louisiana State Employees Retirement System Acquires Shares of 10,500 Enpro Inc. (NYSE:NPO)
marketbeat.com - April 20 at 5:41 AM
Enpro Inc. (NPO)Enpro Inc. (NPO)
finance.yahoo.com - April 19 at 1:58 PM
Enpro Inc. (NYSE:NPO) Shares Sold by Mutual of America Capital Management LLCEnpro Inc. (NYSE:NPO) Shares Sold by Mutual of America Capital Management LLC
marketbeat.com - April 11 at 10:40 AM
Redwood Investments LLC Lowers Holdings in Enpro Inc. (NYSE:NPO)Redwood Investments LLC Lowers Holdings in Enpro Inc. (NYSE:NPO)
marketbeat.com - April 1 at 6:48 AM
Calculating The Intrinsic Value Of Enpro Inc. (NYSE:NPO)Calculating The Intrinsic Value Of Enpro Inc. (NYSE:NPO)
finance.yahoo.com - March 29 at 1:18 PM
Enpro (NYSE:NPO) Reaches New 1-Year High at $167.39Enpro (NYSE:NPO) Reaches New 1-Year High at $167.39
marketbeat.com - March 28 at 4:35 PM
NPO Sep 2024 150.000 callNPO Sep 2024 150.000 call
finance.yahoo.com - March 19 at 4:10 PM
NPO Sep 2024 115.000 putNPO Sep 2024 115.000 put
finance.yahoo.com - March 19 at 4:10 PM
NPO Apr 2024 210.000 callNPO Apr 2024 210.000 call
finance.yahoo.com - March 16 at 1:33 AM
Enpro to Present at the Sidoti Spring Small Cap ConferenceEnpro to Present at the Sidoti Spring Small Cap Conference
businesswire.com - March 8 at 10:00 AM
NPO Mar 2024 70.000 putNPO Mar 2024 70.000 put
ca.finance.yahoo.com - March 3 at 8:32 PM
Interested In Enpros (NYSE:NPO) Upcoming US$0.30 Dividend? You Have Two Days LeftInterested In Enpro's (NYSE:NPO) Upcoming US$0.30 Dividend? You Have Two Days Left
finance.yahoo.com - March 2 at 1:02 PM
Director van der Graaf Kees Sells Shares of Enpro Inc (NPO)Director van der Graaf Kees Sells Shares of Enpro Inc (NPO)
finance.yahoo.com - March 1 at 3:16 PM
Robert S. McLean Implements A Sell Strategy: Offloads $1.01M In Enpro StockRobert S. McLean Implements A Sell Strategy: Offloads $1.01M In Enpro Stock
benzinga.com - February 29 at 1:32 PM
Enpro Inc (NPO) EVP, GC, CAO & Secretary Robert Mclean Sells 6,400 SharesEnpro Inc (NPO) EVP, GC, CAO & Secretary Robert Mclean Sells 6,400 Shares
finance.yahoo.com - February 29 at 7:40 AM
NPO Mar 2024 130.000 putNPO Mar 2024 130.000 put
ca.finance.yahoo.com - February 25 at 5:59 PM
Enpro (NPO) Price Target Increased by 7.16% to 178.16Enpro (NPO) Price Target Increased by 7.16% to 178.16
msn.com - February 24 at 10:12 AM
EnPro Industries, Inc. (NYSE:NPO) Q4 2023 Earnings Call TranscriptEnPro Industries, Inc. (NYSE:NPO) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 21 at 1:55 PM
KeyBanc Keeps Their Buy Rating on Enpro (NPO)KeyBanc Keeps Their Buy Rating on Enpro (NPO)
markets.businessinsider.com - February 21 at 8:54 AM
Enpro Full Year 2023 Earnings: Misses ExpectationsEnpro Full Year 2023 Earnings: Misses Expectations
finance.yahoo.com - February 21 at 8:54 AM
Why Enpro Stock Is Falling TodayWhy Enpro Stock Is Falling Today
msn.com - February 20 at 3:27 PM
Why Enpro Stock Is Falling TodayWhy Enpro Stock Is Falling Today
fool.com - February 20 at 1:27 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Knight Therapeutics logo

Knight Therapeutics

TSE:GUD
Knight Therapeutics Inc. develops, manufactures, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices worldwide. It offers Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib for metastatic cholangiocarcinoma; Akynzeo for prevention of chemotherapy-induced acute and delayed nausea and vomiting; Aloxi for prevention of acute nausea and vomiting associated with emetogenic cancer chemotherapy; Fostamatinib for chronic immune thrombocytopenia; Nerlynx for extended adjuvant breast cancer and metastatic breast cancer; Trelstar for advanced prostate cancer; Vidaza for myelodysplastic syndrome; Abraxane for metastatic pancreatic cancer; Halaven for metastatic breast cancer and soft tissue sarcoma; and Lenvima for advanced renal cell cancer and for differentiated thyroid cancer and unresectable hepatocellular carcinoma. The company provides Ladecvina for multiple myeloma and myelodysplastic syndrome, mantle cell lymphoma, and follicular lymphoma; Zyvalix for metastatic prostate cancer; Karfib for relapsed or refractory multiple myeloma; Leprid for advanced prostate cancer; Rembre for chronic myeloid leukemia; Palbocil for breast cancer; Ambisome and Cresemba for fungal infection; Impavido for leishmaniasis; Dolufevir for HIV infection; Exelon for dementia; and Ibsrela for irritable bowel syndrome with constipation. In addition, it offers Salofalk for ulcerative colitis; Ursofalk for biliary cirrhosis; Imvexxy for moderate to severe dyspareunia; Bijuva for vasomotor symptoms; Fibridoner for idiopathic pulmonary fibrosis; Toliscrin DPI for pseudomonas aeruginosa lung infection; Toliscrin 1-2 for severe acute or resistant chronic infections; and Tobradosa Haler for chronic lung infections. Further, it finances other life science companies; and invests in life sciences venture capital funds. The company was incorporated in 2013 and is headquartered in Montreal, Canada.
Hollysys Automation Technologies logo

Hollysys Automation Technologies

NASDAQ:HOLI
Hollysys Automation Technologies Ltd. provides automation control system solutions in the People's Republic of China, Southeast Asia, India, and the Middle East. The company offers a suite of industrial automation systems, including hardware-centric products, such as instrumentation and actuators; proprietary software-centric distributed control systems/programmable logic controllers; and valued-added software packages comprising simulation training system, HolliAS asset management system, advanced process control, and manufacturing execution system, as well as HOLLiAS MACS-N DCS, a proprietary nuclear power non-safety automation and control system. It provides train control center, an on-ground control center that monitors route condition, track status, train schedules, distance between trains, and the working status of other function devices, as well as generates control instructions and commands. In addition, the company offers automation train protection that operates as a train over-speed protection mechanism; other signaling products, including automatic train operation system, track circuit, line-side electronic unit, balise transmission module, temporary speed restriction server, radio block center, and computer-based interlocking; and supervisory control and data acquisition system, an open software platform. Further, it offers integrated automation control system solutions, mechanical and electrical solutions, including design, engineering, procurement, project management, construction and commissioning, and maintenance related services, and installation services. The company was formerly known as HLS Systems International Ltd. and changed its name to Hollysys Automation Technologies Ltd. in July 2009. Hollysys Automation Technologies Ltd. was founded in 1993 and is headquartered in Beijing, the People's Republic China.
Kadant logo

Kadant

NYSE:KAI
Kadant Inc. supplies technologies and engineered systems worldwide. It operates in three segments: Flow Control, Industrial Processing, and Material Handling. The Flow Control segment develops, manufactures, and markets fluid-handling systems and equipment, such as rotary joints, syphons, turbulator bars, expansion joints, and engineered steam and condensate systems; and doctoring, cleaning, and filtration systems and related consumables consisting of doctor systems and holders, doctor blades, cleaning shower and fabric-conditioning systems, forming systems and wear surfaces, and water-filtration systems. The Industrial Processing segment develops, manufactures, and markets ring and rotary debarkers, stranders, chippers, engineered knife systems, industrial automation and control, recycling and approach flow systems, and virgin pulping process equipment for use in the packaging, tissue, wood products, and alternative fuel industries. The Material Handling segment offers conveying and vibratory equipment, and baling products; and manufactures and sells biodegradable absorbent granules for carriers in agricultural, home lawn and garden, professional lawn, turf, and ornamental applications, as well as for oil and grease absorption. The company markets and sells its products, services, and systems through direct sales, independent sales agents, and distributors. The company was formerly known as Thermo Fibertek, Inc. and changed its name to Kadant Inc. in July 2001. Kadant Inc. was incorporated in 1991 and is headquartered in Westford, Massachusetts.
Enpro logo

Enpro

NYSE:NPO
Enpro Inc. design, develops, manufactures, and markets proprietary, value-added products and solutions to safeguard critical environments in the United States, Europe, and internationally. It operates through two segments, Sealing Technologies and Advanced Surface Technologies. The Sealing Technologies segment offers single-use hygienic seals, tubing, components and assemblies; metallic, non-metallic, and composite material gaskets; dynamic seals; compression packing; hydraulic components; expansion joints; and wall penetration products for chemical and petrochemical processing, pulp and paper processing, nuclear energy, hydrogen, natural gas, food and biopharmaceutical processing, primary metal manufacturing, mining, water and waste treatment, commercial vehicle, aerospace, medical, filtration, and semiconductor fabrication industries. The Advanced Surface Technologies segment offers cleaning, coating, testing, refurbishment, and verification services for critical components and assemblies used in semiconductor manufacturing equipment, as well as for critical applications in the space, aerospace, and defense markets; and specialized optical filters and thin-film coatings for various applications in the industrial technology, life sciences, and semiconductor markets. The company was formerly known as EnPro Industries, Inc. and changed its name to Enpro Inc. in December 2023. Enpro Inc. was incorporated in 2002 and is headquartered in Charlotte, North Carolina.